Security key
92511W108
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 8,314,673
- Share change
- +8,314,673
- Total reported value
- $164,045,000
- Price per share
- $19.73
- Number of holders
- 28
- Value change
- +$164,044,999
- Number of buys
- 28
Report period
Q2 2018
Institutions
28
Top holders
10
VRCA full security history
Newer quarter: Q3 2018
Verrica Pharmaceuticals Inc. SEC filings
Verrica Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92511W108
Recent filing periods:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2018
As of 30 Jun 2018,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,314,673 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, FMR LLC, Fosun International Ltd, FIL Ltd, GILDER GAGNON HOWE & CO LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, CONNING INC., SPHERA FUNDS MANAGEMENT LTD., and Monashee Investment Management LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2018 holders
28
Holder diff
27
| Investor | Q3 2025 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.